8 completed. 8 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 8 | Completed 8 |
Follow ESRD: new trials by email Literature Review of ESRD trials Research Report on ESRD
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| SAfety of Regional Citrate Anticoagulation (SARCA Study) Dialysis - Acute Kidney Injury, ESRD | Phase 3 | Completed | Fresenius Medical Care North America | 32 | 2023-10-17 | 2026-09-11 |
| A Study Testing the Use of a Perivascular Sirolimus Formulation (Sirogen) in ESRD Patients Undergoing AV Fistula Surgery Sirolimus - Complication of Renal Dialysis, End Stage Renal Disease | Phase 3 | Completed | Vascular Therapies, Inc. | 136 | 2022-08-26 | 2026-10-06 |
| Ferric Citrate for the Treatment of Hyperphosphatemia in Patients With Chronic Kidney Disease Undergoing Hemodialysis Ferric Citrate, Sevelamer Carbonate - Hyperphosphatemia, End Stage Renal Disease | Phase 3 | Completed | Panion & BF Biotech Inc. | 240 | 2019-06-19 | 2021-03-10 |
| Ferric Citrate for the Treatment of Hyperphosphatemia in Patients With Chronic Kidney Disease Undergoing Hemodialysis Ferric citrate tablet, Sevelamer carbonate tablet - Hyperphosphatemia, End Stage Renal Disease | Phase 3 | Completed | Sinomune Pharmaceutical Co., Ltd | 239 | 2019-05-24 | 2024-04-17 |
| Trial to Evaluate the Sirolimus-Eluting Collagen Implant on AV Fistula Outcomes Sirolimus, AV Fistula Surgery, Sirolimus-eluting Collagen Implant (SeCI) - Complication of Renal Dialysis, End Stage Renal Disease | Phase 3 | Completed | Vascular Therapies, Inc. | 269 | 2015-11-01 | 2025-10-09 |
| A Long-Term Safety Extension Trial of Ferric Citrate in Patients With End-Stage Renal Disease (ESRD) on Dialysis ferric citrate - End Stage Renal Disease, Kidney Failure | Phase 3 | Completed | Keryx Biopharmaceuticals | 168 | 2012-08-01 | 2016-07-13 |
| A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of the Effects of Ferric Citrate in Subjects With End Stage Renal Disease ferric citrate - Hyperphosphatemia, End Stage Renal Disease | Phase 3 | Completed | Panion & BF Biotech Inc. | 183 | 2010-06-01 | 2020-01-13 |
| IMPENDIA- PEN VS Dianeal Only Improved Metabolic Control In Diabetic CAPD and APD Patients Dianeal, Physioneal, Extraneal - ESRD, Diabetes | Phase 3 | Completed | Vantive Health LLC | 43 | 2008-04-01 | 2025-07-22 |
Kidney Failure, Chronic (8) · Hyperphosphatemia (4) · Renal Insufficiency (3) · Renal Insufficiency, Chronic (3) · Arteriovenous Fistula (2) · Kidney Diseases (2) · Phosphorus Metabolism Disorders (2) · Acute Kidney Injury (1) · Diabetes Mellitus (1) · Urologic Diseases (1)
Chronic Disease (8) · Disease Attributes (8) · Female Urogenital Diseases (8) · Female Urogenital Diseases and Pregnancy Complications (8) · Male Urogenital Diseases (8) · Pathologic Processes (8) · Pathological Conditions, Signs and Symptoms (8) · Urogenital Diseases (8) · Urologic Diseases (7) · Kidney Diseases (6) · Metabolic Diseases (5) · Nutritional and Metabolic Diseases (5) · Renal Insufficiency (5) · Renal Insufficiency, Chronic (5) · Arteriovenous Malformations (2)
ferric citrate (4) · Sevelamer (2) · Sirolimus (2) · Dialysis (1) · Icodextrin (1) · Nutrineal (1)
Panion & BF Biotech Inc. (2) · Vascular Therapies, Inc. (2) · Fresenius Medical Care North America (1) · Keryx Biopharmaceuticals (1) · Sinomune Pharmaceutical Co., Ltd (1) · Vantive Health LLC (1)
United States (4) · China (2) · Australia (1) · Canada (1) · New Zealand (1) · Puerto Rico (1) · Taiwan (1) · United Kingdom (1)
Sriram Iyer, MD (2) · Julia B Lewis, MD (1) · Manuela Stauss-Grabo, PhD (1) · Xiangmei Chen (1)